MAZE logo

Maze Therapeutics, Inc. (MAZE) Cash From Operations

Annual CFO:

$75.95M+$162.78M(+187.48%)
December 31, 2024

Summary

  • As of today, MAZE annual cash from operations is $75.95 million, with the most recent change of +$162.78 million (+187.48%) on December 31, 2024.
  • During the last 3 years, MAZE annual cash from operations has risen by +$175.16 million (+176.56%).
  • MAZE annual cash from operations is now at all-time high.

Performance

1-Year Change

+187.48%

3-Year Change

+176.56%

5-Year Change

+176.56%

15-Year Change

+176.56%

MAZE Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

85%
MAZE annual cash from operations is higher than 85% of companies in Healthcare sector

Range

All-Time High

$75.95M
MAZE annual cash from operations is currently at an all-time high

3-Year Low

-$99.20M
MAZE annual cash from operations is currently +176.56% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
MAZE previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 5, 2026
MAZE next annual earnings announcement is scheduled for Mar 5, 2026

OtherMAZEcash flow metrics

Annual CFI

-$1.15M
MAZE annual cash from investing is -$1.15 million

Annual CFF

$92.85M
MAZE annual cash from financing is $92.85 million

Annual FCF

$74.81M
MAZE annual free cash flow is $74.81 million

Annual CAPEX

$1.15M
MAZE annual capital expenditures is $1.15 million

Quarterly CFO:

-$24.64M+$5.41M(+18.00%)
September 30, 2025

Summary

  • As of today, MAZE quarterly cash from operations is -$24.64 million, with the most recent change of +$5.41 million (+18.00%) on September 30, 2025.
  • MAZE quarterly cash from operations is now -19.37% below its all-time high of -$20.64 million, reached on December 31, 2023.

Performance

3-Month Change

+18%

1-Year Change

-

3-Year Change

+62.77%

5-Year Change

+62.77%

MAZE Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

15.34%
MAZE quarterly cash from operations is higher than 15.34% of companies in Healthcare sector

Range

All-Time High

-$20.64M
MAZE quarterly cash from operations is currently -19.37% below its historical high of -$20.64 million

3-Year Low

-$66.18M
MAZE quarterly cash from operations is currently +62.77% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
MAZE previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 5, 2026
MAZE next earnings announcement is scheduled for Mar 5, 2026

OtherMAZEcash flow metrics

Quarterly CFI

-$66.88M
MAZE quarterly cash from investing is -$66.88 million

Quarterly CFF

$143.76M
MAZE quarterly cash from financing is $143.76 million

Quarterly FCF

-$24.71M
MAZE quarterly free cash flow is -$24.71 million

Quarterly CAPEX

$68.00K
MAZE quarterly capital expenditures is $68.00 thousand

TTM CFO:

-$106.66M-$24.64M(-30.04%)
September 30, 2025

Summary

  • As of today, MAZE TTM cash from operations is -$106.66 million, with the most recent change of -$24.64 million (-30.04%) on September 30, 2025.
  • MAZE TTM cash from operations is now -132.43% below its all-time high of -$45.89 million, reached on December 31, 2024.

Performance

3-Month Change

-30.04%

1-Year Change

-

3-Year Change

-61.16%

5-Year Change

-61.16%

MAZE TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

13.25%
MAZE TTM cash from operations is higher than 13.25% of companies in Healthcare sector

Range

All-Time High

-$45.89M
MAZE TTM cash from operations is currently -132.43% below its historical high of -$45.89 million

3-Year Low

-$110.26M
MAZE TTM cash from operations is currently +3.27% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
MAZE previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 5, 2026
MAZE next earnings announcement is scheduled for Mar 5, 2026

OtherMAZEcash flow metrics

TTM CFI

-$68.18M
MAZE TTM cash from investing is -$68.18 million

TTM CFF

$342.01M
MAZE TTM cash from financing is $342.01 million

TTM FCF

-$108.03M
MAZE TTM free cash flow is -$108.03 million

TTM CAPEX

$1.36M
MAZE TTM capital expenditures is $1.36 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

MAZE Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+187.5%--
3Y3 Years+176.6%+62.8%-61.2%
5Y5 Years+176.6%+62.8%-61.2%

MAZE Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+176.6%-19.4%+62.8%-132.4%+3.3%
5Y5-Yearat high+176.6%-19.4%+62.8%-132.4%+3.3%
All-TimeAll-Timeat high+176.6%-19.4%+62.8%-132.4%+3.3%

MAZE Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
-$24.64M(+18.0%)
-$106.66M(-30.0%)
Jun 2025
-
-$30.05M(-1.8%)
-$82.02M(-57.8%)
Mar 2025
-
-$29.52M(-31.5%)
-$51.97M(-13.2%)
Dec 2024
$75.95M
-$22.45M(+4.2%)
-$45.89M(+58.4%)
DateAnnualQuarterlyTTM
Mar 2024
-
-$23.44M(-13.5%)
-$110.26M(-27.0%)
Dec 2023
-$86.83M(+12.5%)
-$20.64M(+68.8%)
-$86.83M(-31.2%)
Sep 2023
-
-$66.18M
-$66.18M
Dec 2022
-$99.20M
-
-

FAQ

  • What is Maze Therapeutics, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. annual cash from operations year-on-year change?
  • What is Maze Therapeutics, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Maze Therapeutics, Inc.?

What is Maze Therapeutics, Inc. annual cash from operations?

The current annual cash from operations of MAZE is $75.95M

What is the all-time high annual cash from operations for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high annual cash from operations is $75.95M

What is Maze Therapeutics, Inc. annual cash from operations year-on-year change?

Over the past year, MAZE annual cash from operations has changed by +$162.78M (+187.48%)

What is Maze Therapeutics, Inc. quarterly cash from operations?

The current quarterly cash from operations of MAZE is -$24.64M

What is the all-time high quarterly cash from operations for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high quarterly cash from operations is -$20.64M

What is Maze Therapeutics, Inc. TTM cash from operations?

The current TTM cash from operations of MAZE is -$106.66M

What is the all-time high TTM cash from operations for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high TTM cash from operations is -$45.89M
On this page